| Bharat Parenterals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541096 |
NSE Symbol : - |
P/E(TTM) : 38.12 |
|
ISIN Demat : INE365Y01019 |
Div & Yield% : 0.11 |
EPS(TTM) : 24.55 |
|
Book Value(₹) : 578.78 |
Market Cap(₹Cr) : 644.95 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 41.41 | 41.70 | 94.37 | 80.28 | 67.34 | 64.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 41.41 | 41.70 | 94.37 | 80.28 | 67.34 | 64.45 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.28 | 4.21 | 1.62 | 2.26 | 3.79 | 4.60 |
| Total Income | 43.69 | 45.91 | 95.99 | 82.54 | 71.13 | 69.05 |
| Total Expenditure | 37.94 | 39.37 | 79.11 | 75.70 | 58.99 | 58.79 |
| PBIDT | 5.75 | 6.54 | 16.88 | 6.84 | 12.14 | 10.26 |
| Interest | 0.55 | 0.96 | 1.42 | 1.48 | 1.41 | 0.88 |
| PBDT | 5.20 | 5.59 | 15.46 | 5.36 | 10.73 | 9.38 |
| Depreciation | 2.10 | 2.17 | 2.06 | 1.82 | 1.86 | 1.75 |
| Tax | 0.83 | 1.14 | 3.70 | 1.33 | 2.51 | 2.38 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.35 | -0.45 | -0.30 | -0.07 | -0.15 | -0.24 |
| Reported Profit After Tax | 1.92 | 2.73 | 10.00 | 2.28 | 6.50 | 5.49 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.92 | 2.73 | 10.00 | 2.28 | 6.50 | 5.49 |
| EPS (Unit Curr.) | 2.78 | 3.96 | 14.51 | 3.48 | 8.30 | 7.90 |
| EPS (Adj) (Unit Curr.) | 2.78 | 3.96 | 14.51 | 3.48 | 8.30 | 7.90 |
| Calculated EPS (Unit Curr.) | 2.78 | 3.96 | 14.51 | 3.31 | 9.44 | 8.41 |
| Calculated EPS (Adj) (Unit Curr.) | 2.78 | 3.96 | 14.51 | 3.31 | 9.44 | 8.41 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.12 | 15.83 | 58.06 | 13.24 | 37.75 | 33.66 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.12 | 15.83 | 58.06 | 13.24 | 37.75 | 33.66 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.89 | 6.89 | 6.89 | 6.89 | 6.89 | 6.52 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.89 | 15.68 | 17.89 | 8.52 | 18.03 | 15.92 |
| PBDTM(%) | 12.56 | 13.41 | 16.38 | 6.68 | 15.93 | 14.55 |
| PATM(%) | 4.64 | 6.55 | 10.60 | 2.84 | 9.65 | 8.52 |